Skip to content

Comparative Study of High Performance Low-Cost Optical Coherence Tomography

Comparative Study of High Performance Low-Cost Optical Coherence Tomography

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05530460
Enrollment
11
Registered
2022-09-07
Start date
2024-03-22
Completion date
2024-05-17
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optical Coherence Tomography of Retina

Brief summary

The purpose of this study is to complete performance testing of our custom optical coherence tomography (OCT) device to verify it can deliver retinal images of similar quality to a commercial OCT device.

Detailed description

There is some evidence that certain changes in retinal structures could be an indicator of Alzheimer's disease (AD). We are developing a new technology that combines optical coherence tomography (OCT) and angle-resolved low coherence interferometry (a/LCI) to make light scattering measurements of retinal tissue structure. The objective of this device feasibility study is to compare performance characteristics of our custom OCT instrument to a commercial OCT instrument. Once we have optimized our device, we may use it in future studies to identify retinal structure changes that could be possible AD biomarkers. For this study, the team will recruit healthy volunteers to attend one study visit that is about 30 minutes long. This visit will include examination with our custom OCT instrument, followed by examination with a commercial OCT system.

Interventions

DEVICEretinal imaging with low-cost OCT device

Retinal imaging with low-cost OCT device

DEVICEretinal imaging with commercial OCT device

retinal imaging with commercial OCT device

Sponsors

Duke University
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* able to provide informed consent

Exclusion criteria

* potentially confounding ocular conditions, such as: glaucoma, current corneal injury, retinal damage, diabetes, corrected distance visual acuity worse than 20/40 * eyes that have had intraocular surgery, other than cataract surgery If two eyes satisfy the inclusion /

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with Acceptable OCT Image Quality as Measured by Low-Cost OCT Deviceduring study procedures (30 minutes)measured by: ability to see clearly defined and recognizable structures of the retina with the low-cost OCT device.

Secondary

MeasureTime frameDescription
Contrast-to-Noise Ratio (CNR)during study procedures (30 minutes)Measure of OCT image quality comparing level of image contrast to level of background noise. CNR = (mean of signal of region of interest \[i.e., retina\] - mean of background noise) divided by square root of (the square of the standard deviation of the region of interest + the square of the standard deviation of the background noise). Therefore, CNR is unitless.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAdam Wax, Ph.D.

Duke University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026